Global Cancer Biopsy Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3600/- USD | Published Date: July 19, 2021 |

The global cancer biopsy market size is anticipated to register a significant CAGR of over 6% during the forecast period 2021 to 2027 and was estimated at around USD 20 billion in 2020. The increasing prevalence of cancer and the rising awareness regarding early detection of cancer are some major factors driving the market growth. The technological advancement in molecular medicine has improved the classification of cancer which is further expected to drive the market. The advancement in image-guided biopsies and their increasing applications are some key trends in the market. In addition, the increasing investment in research & development is anticipated to uplift the market growth over the forecast period.

Market Segment Insights:

The global cancer biopsy market is bifurcated into type, product, application, and geography. On the basis of product, the market is further segmented into instruments, kits and consumables, and services. The kits & consumables segment dominated the market in 2020 and accounted to hold the largest market share of around two-third share of the market. The large investment by some major players is a key factor to drive the segment growth. Furthermore, the manufacturers are focusing to launch advanced products to enhance biopsy which is further expected to boost the segment growth over the forecast period.

Based on the application, the market is segmented into breast cancer, colorectal cancer, cervical cancers, lung cancers, prostate cancers, skin cancers, and other cancers. The breast cancer segment dominated the global cancer biopsy market in 202 and held the largest revenue share of around 15% of the market. As per latest information shared by World Health Organization (WHO), 2.3 million women were diagnosed with breast cancer in 2020 and 685,000 death were recorded due to breast cancer globally.

Cancer Biopsy Market Size & Forecast

To know more about the report, request sample papers

The cancer biopsy comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2021 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The cancer biopsy market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Cancer Biopsy Market Segmentation:

By Product:

  • Instruments
  • Kits and Consumables
  • Services

By Type:

  • Tissue Biopsies
  • Liquid Biopsies
  • Others

By Application:

  • Breast Cancer
  • Colorectal Cancer
  • Cervical Cancers
  • Lung Cancers
  • Prostate Cancers
  • Skin Cancers
  • Blood Cancers
  • Kidney Cancers
  • Liver Cancers
  • Pancreatic Cancers
  • Ovarian Cancers
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

Geographically, North America dominated the global cancer biopsy market in 2020 and estimated to hold the largest market share of over one-third share of the market in terms of revenue. As per the American Cancer Society, it is estimated that 1.9 million new cancer cases will be diagnosed and in 2021 and 608,570 people will die due to the cancer disease. The increasing adoption of liquid biopsies and supportive regulatory strategies is expected to drive the market growth in the region. Furthermore, the presence of some major players and the increasing investment by manufacturers is projected to boost the market growth in North America.

Market Competition Assessment:

Some of the major players operating in the global cancer biopsy market are Becton, Dickinson And Company, Qiagen N.V., Illumina, Inc., ANGLE Plc, and Myriad Genetics. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Becton, Dickinson And Company
  • Qiagen N.V.
  • Illumina, Inc.
  • ANGLE Plc
  • Myriad Genetics
  • Thermo Fisher Scientific, Inc.
  • Hologic, Inc.
  • Biocept, Inc.
  • Danaher
  • Hoffmann-La Roche Ltd.

Key Questions Answered by Cancer Biopsy Market Report

  • Global cancer biopsy market forecasts from 2021-2027
  • Regional cancer biopsy market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East and Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Cancer biopsy submarket forecasts from 2021-2027 covering the market by type, by product, by application, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to the cancer biopsy market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level cancer biopsy markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the cancer biopsy market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Cancer Biopsy Market Portraiture
2.2. Global Cancer Biopsy Market, by Product, 2020 (USD Mn)
2.3. Global Cancer Biopsy Market, by Type, 2020 (USD Mn)
2.4. Global Cancer Biopsy Market, by Application, 2020 (USD Mn)
2.5. Global Cancer Biopsy Market, by Geography, 2020 (USD Mn)

 

3. Global Cancer Biopsy Market Analysis


3.1. Cancer Biopsy Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis

 

4. Global Cancer Biopsy Market By Product, 2018 – 2027 (USD Mn)


4.1. Overview
4.2. Instruments
4.3. Kits and Consumables
4.4. Services

 

5. Global Cancer Biopsy Market By Type, 2018 – 2027 (USD Mn)


5.1. Overview
5.2. Tissue Biopsies
5.3. Liquid Biopsies
5.4. Others

 

6. Global Cancer Biopsy Market By Application, 2018 – 2027 (USD Mn)


6.1. Overview
6.2. Breast Cancer
6.3. Colorectal Cancer
6.4. Cervical Cancers
6.5. Lung Cancers
6.6. Prostate Cancers
6.7. Skin Cancers
6.8. Blood Cancers
6.9. Kidney Cancers
6.10. Liver Cancers
6.11. Pancreatic Cancers
6.12. Ovarian Cancers
6.13. Others

 

7. North America Cancer Biopsy Market Analysis and Forecast, 2018 – 2027 (USD Mn)


7.1.1. Overview
7.1.2. North America Cancer Biopsy Market by Product (2018-2027 USD Mn)
7.1.3. North America Cancer Biopsy Market by Type (2018-2027 USD Mn)
7.1.4. North America Cancer Biopsy Market by Application (2018-2027 USD Mn)
7.1.5. North America Cancer Biopsy Market by Country (2018-2027 USD Mn)
7.1.5.1. U.S.
7.1.5.1.1. U.S. Cancer Biopsy Market by Product (2018-2027 USD Mn)
7.1.5.1.2. U.S. Cancer Biopsy Market by Type (2018-2027 USD Mn)
7.1.5.1.3. U.S. Cancer Biopsy Market by Application (2018-2027 USD Mn)
7.1.5.2. Canada
7.1.5.2.1. Canada Cancer Biopsy Market by Product (2018-2027 USD Mn)
7.1.5.2.2. Canada Cancer Biopsy Market by Type (2018-2027 USD Mn)
7.1.5.2.3. Canada Cancer Biopsy Market by Application (2018-2027 USD Mn)

 

8. Europe Cancer Biopsy Market Analysis and Forecast, 2018 – 2027 (USD Mn)


8.1.1. Overview
8.1.2. Europe Cancer Biopsy Market by Product (2018-2027 USD Mn)
8.1.3. Europe Cancer Biopsy Market by Type (2018-2027 USD Mn)
8.1.4. Europe Cancer Biopsy Market by Application (2018-2027 USD Mn)
8.1.5. Europe Cancer Biopsy Market by Country (2018-2027 USD Mn)
8.1.5.1. Germany
8.1.5.1.1. Germany Cancer Biopsy Market by Product (2018-2027 USD Mn)
8.1.5.1.2. Germany Cancer Biopsy Market by Type (2018-2027 USD Mn)
8.1.5.1.3. Germany Cancer Biopsy Market by Application (2018-2027 USD Mn)
8.1.5.2. U.K.
8.1.5.2.1. U.K. Cancer Biopsy Market by Product (2018-2027 USD Mn)
8.1.5.2.2. U.K. Cancer Biopsy Market by Type (2018-2027 USD Mn)
8.1.5.2.3. U.K. Cancer Biopsy Market by Application (2018-2027 USD Mn)
8.1.5.3. France
8.1.5.3.1. France Cancer Biopsy Market by Product (2018-2027 USD Mn)
8.1.5.3.2. France Cancer Biopsy Market by Type (2018-2027 USD Mn)
8.1.5.3.3. France Cancer Biopsy Market by Application (2018-2027 USD Mn)
8.1.5.4. Italy
8.1.5.4.1. Italy Cancer Biopsy Market by Product (2018-2027 USD Mn)
8.1.5.4.2. Italy Cancer Biopsy Market by Type (2018-2027 USD Mn)
8.1.5.4.3. Italy Cancer Biopsy Market by Application (2018-2027 USD Mn)
8.1.5.5. Rest of Europe
8.1.5.5.1. Rest of Europe Cancer Biopsy Market by Product (2018-2027 USD Mn)
8.1.5.5.2. Rest of Europe Cancer Biopsy Market by Type (2018-2027 USD Mn)
8.1.5.5.3. Rest of Europe Cancer Biopsy Market by Application (2018-2027 USD Mn)

 

9. Asia Pacific Cancer Biopsy Market Analysis and Forecast, 2018 – 2027 (USD Mn)


9.1.1. Overview
9.1.2. Asia Pacific Cancer Biopsy Market by Product (2018-2027 USD Mn)
9.1.3. Asia Pacific Cancer Biopsy Market by Type (2018-2027 USD Mn)
9.1.4. Asia Pacific Cancer Biopsy Market by Application (2018-2027 USD Mn)
9.1.5. Asia Pacific Cancer Biopsy Market by Country (2018-2027 USD Mn)
9.1.5.1. China
9.1.5.1.1. China Cancer Biopsy Market by Product (2018-2027 USD Mn)
9.1.5.1.2. China Cancer Biopsy Market by Type (2018-2027 USD Mn)
9.1.5.1.3. China Cancer Biopsy Market by Application (2018-2027 USD Mn)
9.1.5.2. Japan
9.1.5.2.1. Japan Cancer Biopsy Market by Product (2018-2027 USD Mn)
9.1.5.2.2. Japan Cancer Biopsy Market by Type (2018-2027 USD Mn)
9.1.5.2.3. Japan Cancer Biopsy Market by Application (2018-2027 USD Mn)
9.1.5.3. Rest of Asia Pacific
9.1.5.3.1. Rest of Asia Pacific Cancer Biopsy Market by Product (2018-2027 USD Mn)
9.1.5.3.2. Rest of Asia Pacific Cancer Biopsy Market by Type (2018-2027 USD Mn)
9.1.5.3.3. Rest of Asia Pacific Cancer Biopsy Market by Application (2018-2027 USD Mn)

 

10. Latin America (LATAM) Cancer Biopsy Market Analysis and Forecast, 2018 – 2027 (USD Mn)


10.1.1. Overview
10.1.2. Latin America Cancer Biopsy Market by Product (2018-2027 USD Mn)
10.1.3. Latin America Cancer Biopsy Market by Type (2018-2027 USD Mn)
10.1.4. Latin America Cancer Biopsy Market by Application (2018-2027 USD Mn)
10.1.5. Latin America Cancer Biopsy Market by Country (2018-2027 USD Mn)
10.1.5.1. Brazil
10.1.5.1.1. Brazil Cancer Biopsy Market by Product (2018-2027 USD Mn)
10.1.5.1.2. Brazil Cancer Biopsy Market by Type (2018-2027 USD Mn)
10.1.5.1.3. Brazil Cancer Biopsy Market by Application (2018-2027 USD Mn)
10.1.5.2. Mexico
10.1.5.2.1. Mexico Cancer Biopsy Market by Product (2018-2027 USD Mn)
10.1.5.2.2. Mexico Cancer Biopsy Market by Type (2018-2027 USD Mn)
10.1.5.2.3. Mexico Cancer Biopsy Market by Application (2018-2027 USD Mn)
10.1.5.3. Rest of Latin America
10.1.5.3.1. Rest of Latin America Cancer Biopsy Market by Product (2018-2027 USD Mn)
10.1.5.3.2. Rest of Latin America Cancer Biopsy Market by Type (2018-2027 USD Mn)
10.1.5.3.3. Rest of Latin America Cancer Biopsy Market by Application (2018-2027 USD Mn)

 

11. Middle East and Africa Cancer Biopsy Market Analysis and Forecast, 2018 – 2027 (USD Mn)


11.1.1. Overview
11.1.2. MEA Cancer Biopsy Market by Product (2018-2027 USD Mn)
11.1.3. MEA Cancer Biopsy Market by Type (2018-2027 USD Mn)
11.1.4. MEA Cancer Biopsy Market by Application (2018-2027 USD Mn)
11.1.5. Middle East and Africa Cancer Biopsy Market, by Country (2018-2027 USD Mn)
11.1.5.1. GCC
11.1.5.1.1. GCC Cancer Biopsy Market by Product (2018-2027 USD Mn)
11.1.5.1.2. GCC Cancer Biopsy Market by Type (2018-2027 USD Mn)
11.1.5.1.3. GCC Cancer Biopsy Market by Application (2018-2027 USD Mn)
11.1.5.2. South Africa
11.1.5.2.1. South Africa Cancer Biopsy Market by Product (2018-2027 USD Mn)
11.1.5.2.2. South Africa Cancer Biopsy Market by Type (2018-2027 USD Mn)
11.1.5.2.3. South Africa Cancer Biopsy Market by Application (2018-2027 USD Mn)
11.1.5.3. Rest of MEA
11.1.5.3.1. Rest of MEA Cancer Biopsy Market by Product (2018-2027 USD Mn)
11.1.5.3.2. Rest of MEA Cancer Biopsy Market by Type (2018-2027 USD Mn)
11.1.5.3.3. Rest of MEA Cancer Biopsy Market by Application (2018-2027 USD Mn)

 

12. Company Profiles


12.1. Becton, Dickinson and Company
12.1.1. Business Description
12.1.2. Financial Health and Budget Allocation
12.1.3. Product Positions/Portfolio
12.1.4. Recent Development
12.1.5. SWOT Analysis
12.2. Qiagen N.V.
12.2.1. Business Description
12.2.2. Financial Health and Budget Allocation
12.2.3. Product Positions/Portfolio
12.2.4. Recent Development
12.2.5. SWOT Analysis
12.3. Illumina, Inc.
12.3.1. Business Description
12.3.2. Financial Health and Budget Allocation
12.3.3. Product Positions/Portfolio
12.3.4. Recent Development
12.3.5. SWOT Analysis
12.4. ANGLE Plc
12.4.1. Business Description
12.4.2. Financial Health and Budget Allocation
12.4.3. Product Positions/Portfolio
12.4.4. Recent Development
12.4.5. SWOT Analysis
12.5. Myriad Genetics
12.5.1. Business Description
12.5.2. Financial Health and Budget Allocation
12.5.3. Product Positions/Portfolio
12.5.4. Recent Development
12.5.5. SWOT Analysis
12.6. Thermo Fisher Scientific, Inc.
12.6.1. Business Description
12.6.2. Financial Health and Budget Allocation
12.6.3. Product Positions/Portfolio
12.6.4. Recent Development
12.6.5. SWOT Analysis
12.7. Hologic, Inc.
12.7.1. Business Description
12.7.2. Financial Health and Budget Allocation
12.7.3. Product Positions/Portfolio
12.7.4. Recent Development
12.7.5. SWOT Analysis
12.8. Biocept, Inc.
12.8.1. Business Description
12.8.2. Financial Health and Budget Allocation
12.8.3. Product Positions/Portfolio
12.8.4. Recent Development
12.8.5. SWOT Analysis
12.9. Danaher
12.9.1. Business Description
12.9.2. Financial Health and Budget Allocation
12.9.3. Product Positions/Portfolio
12.9.4. Recent Development
12.9.5. SWOT Analysis
12.10. F. Hoffmann-La Roche Ltd.
12.10.1. Business Description
12.10.2. Financial Health and Budget Allocation
12.10.3. Product Positions/Portfolio
12.10.4. Recent Development
12.10.5. SWOT Analysis
Fill the given form to inquiry before buying for Cancer Biopsy Market Report

Your Designtaion (required):


(Additional country analysis and conmapny analysis will be added according to the request, please read our FAQs below)
(Reports covers the COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying



Frequently Asked Questions (FAQs):
A. Yes, we provide customization with every report to fulfill your market research requirement.
A. No, generally we don’t charge for report customization.
A. Yes, we will add the more coutries analysis in the report, please mention the countries you are looking.
A. Yes, we provide research support for all our clients to resolve their issue regarding the report.
A. Yes, you can purchase only a regional or a country market report with our best price which is less than the global report.
A. Yes, we provide a better discount for startups and individuals.
A. Our database consists of over 70,000 market research reports; if still not available on the website, feel free to write us. Our team will be happy to assist you in the same. Let us know if you are looking for the dataset.
(For more information, feel free to write us at sales@researchcorridor.com)
Select License Type
$3600/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client are returning clients
  • 100,000+ data points in our comprehensive database
  • 24x5 availability - we are always there when you need us
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report

Impacts of COVID-19
COVID-19 Impact on the Cancer Biopsy Market

For Any Assitance

Call Us: +1 520-686-7060
Email: sales@researchcorridor.com

Our Clients